Adrian Sacher, M.D.

493 posts

Adrian Sacher, M.D. banner
Adrian Sacher, M.D.

Adrian Sacher, M.D.

@DocSacher

Lung oncologist, tumor immunology & KRAS researcher, advocate for lung cancer patients and learners @pmcancercentre, @uoftmedicine, @UofT. He/Him/Il. 🏳️‍🌈

Toronto, Ontario | Treaty 13 Katılım Ekim 2015
1.4K Takip Edilen1K Takipçiler
Sabitlenmiş Tweet
Adrian Sacher, M.D.
Adrian Sacher, M.D.@DocSacher·
Setting the bar higher for KRAS inhibitors - pleased to share our study of divarasib in KRAS G12C lung/colon/solid tumors in @NEJM. Impressive response rate, durability and tolerability. Thanks to pts and co-investigators. @KRASKickers #lcsm
NEJM@NEJM

Among patients with cancers bearing the KRAS G12C mutation who received divarasib at a 400-mg dose, 56% with lung cancer, 36% with colorectal cancer, and 36% with other tumor types had a confirmed response. 🔗 Read the full study results: nej.md/45xZYok #oncology

English
5
9
60
7.1K
Adrian Sacher, M.D. retweetledi
Natalie Vokes
Natalie Vokes@NIVokes·
It was a pleasure to spend the day @ASCO planning the metastatic NSCLC program with this amazing group (missing Toby Campbell). Looking forward to an exciting #ASCO25 !
Natalie Vokes tweet media
English
1
6
43
3.2K
Adrian Sacher, M.D. retweetledi
Annals of Oncology
Annals of Oncology@Annals_Oncology·
@HPrenen #ESMO24 concomitant paper: @DocSacher presents the First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor at today's Presidential Symposium @HPrenen
Annals of Oncology tweet media
English
0
4
10
1.4K
Adrian Sacher, M.D. retweetledi
Charu Aggarwal, MD, MPH, FASCO
Charu Aggarwal, MD, MPH, FASCO@CharuAggarwalMD·
Excellent summary of #KRASG12C trials in the metastatic NSCLC space by @DocSacher @ASCO #ASCO24 ✨ 2L tx TKI v. Docetaxel ✨ combination TKI + IO ✨ combination with chemo ✨ combination with EGFR Lot if interest in this space and congrats to all the authors @OncoAlert
Charu Aggarwal, MD, MPH, FASCO tweet mediaCharu Aggarwal, MD, MPH, FASCO tweet mediaCharu Aggarwal, MD, MPH, FASCO tweet mediaCharu Aggarwal, MD, MPH, FASCO tweet media
English
0
28
67
11.1K
Adrian Sacher, M.D. retweetledi
Patrick Forde
Patrick Forde@FordePatrick·
Not one, not 2, but 3 lung cancer plenaries at #ASCO24 ! Early telemed pall care, the LAURA trial of consolidation osimertinib after CRT for stage 3 EGFR non small cell lung cancer & the ADRIATIC trial of consolidation immunotherapy after CRT for small cell lung cancer! #lcsm
ASCO@ASCO

#ASCO24 garnered a record number of abstract submissions! Preview the abstract titles to see what will be presented or published at this year’s meeting and browse the meeting program to start planning your schedule ➡️ brnw.ch/21wJ8kD

English
4
28
113
15.8K
Adrian Sacher, M.D. retweetledi
Brad Wouters 🇨🇦
Brad Wouters 🇨🇦@bradwouters·
Pleased to participate in #Coalition4CdnResearch press conference with all Canadian advocacy groups coming together to call on the federal government to invest in research. @cafreeland @KirstyDuncanMP @JustinTrudeau
Research Canada@ResearchCda

"It's past time for the government to make a major investment in Canadian research." - Dr. Brad Wouters, Executive VP Science & Research at @UHN, representing @HealthCareCAN, and a Research Canada Board Director Read #Coalition4CdnResearch's open letter: ow.ly/yXg450PTuPI

English
4
37
172
27.3K
Adrian Sacher, M.D. retweetledi
Brad Wouters 🇨🇦
Brad Wouters 🇨🇦@bradwouters·
Exciting new clinical findings from @DocSacher @pmcancercentre @UHN_Research demonstrating potential of targeting KRAS
UHN Research@UHN_Research

Dr. Adrian Sacher (@DocSacher) @UHN co-led a multi-national effort to test a new anticancer drug in patients with non-small-cell lung cancer and colon cancer. With few serious side effects found, further testing is warranted. > uhnresearch.ca/news/advancing…; doi.org/10.1056/NEJMoa…

English
0
1
15
2.3K
Adrian Sacher, M.D.
Adrian Sacher, M.D.@DocSacher·
The support of @lcfamerica and patients & their families has been essential to our ongoing work to end lung cancer. Thank you so much - great things to come!
Lung Cancer Foundation of America@lcfamerica

🎓 As a Clinical Investigator and Assistant Professor, Dr. @DocSacher's impact on lung cancer research is undeniable. His dedication to immunotherapy brings hope to patients worldwide. 🏆 #Livingwithlungcancer #LCFAResearch #WLCD23 #lungcancer bit.ly/44Czi5C

English
1
2
19
1.9K
Adrian Sacher, M.D.
Adrian Sacher, M.D.@DocSacher·
Really amazing data on GDC-6036 plus cetuximab in KRAS G12C metastatic colon cancer - ORR 62% !!! More potent KRAS G12C inhibitors make for more effective combos & better options for patients. #AACR23 @KRASKickers
Adrian Sacher, M.D. tweet media
English
1
11
61
7.9K

Keşfet

@IASLC @myESMO @pwheatleyprice @susanebates @ASCO @HPrenen @pmcancercentre @uoftmedicine